Advanced search
Publication Cover
Modern Rheumatology Volume 26, 2016 - Issue 6
Journal homepage
317
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Effectiveness of tacrolimus in comparison with methotrexate or biologics in propensity score-matched patients with rheumatoid arthritis

Ayako NakajimaInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, JapanCorrespondence[email protected]
,
Eisuke InoueInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
,
Atsuo TaniguchiInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
,
Shigeki MomoharaInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
&
Hisashi YamanakaInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
Pages 836-843 | Received 09 Oct 2015, Accepted 27 Feb 2016, Published online: 02 Jun 2016

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Koichiro Ishikawa & Junichiro Ishikawa. (2019) Iguratimod, a synthetic disease modifying anti-rheumatic drug inhibiting the activation of NF-κB and production of RANKL: Its efficacy, radiographic changes, safety and predictors over two years’ treatment for Japanese rheumatoid arthritis patients. Modern Rheumatology 29:3, pages 418-429.
Read now

Articles from other publishers (8)

Kenya Terabe, Nobunori Takahashi, Shuji Asai, Yuji Hirano, Yasuhide Kanayama, Yuichiro Yabe, Takeshi Oguchi, Takayoshi Fujibayashi, Hisato Ishikawa, Masahiro Hanabayashi, Yosuke Hattori, Mochihito Suzuki, Kenji Kishimoto, Yoshifumi Ohashi, Takahiro Imaizumi, Shiro Imagama & Toshihisa Kojima. (2023) Effectiveness of tacrolimus concomitant with biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. Modern Rheumatology 33:2, pages 292-301.
Crossref
Eun Hye Park, Anna Shin, You-Jung Ha, Yun Jong Lee, Eun Bong Lee, Yeong Wook Song & Eun Ha Kang. (2022) Facteurs associés à l’initiation d’un traitement biologique ciblé chez les patients atteints de polyarthrite rhumatoïde : étude cas-témoins intra-cohorte portant sur 34 925 patients. Revue du Rhumatisme 89:3, pages 252-259.
Crossref
Min Jung Kim, Eun Hye Park, Anna Shin, You-Jung Ha, Yun Jong Lee, Eun Bong Lee, Han Joo Baek & Eun Ha Kang. (2022) Assessment on Treatments With Conventional Synthetic Disease-modifying Drugs Before Initiating Biologics in Patients With Rheumatoid Arthritis in Korea: A Population-based Study. Journal of Rheumatic Diseases 29:2, pages 79-88.
Crossref
Salwa Abdel-Tawab IbrahimNashwa Fathy EltahawyAhlam Mohamed AbdallaHanaa Mohamed Khalaf. (2021) Protective effects of selenium in tacrolimus-induced lung toxicity: potential role of heme oxygenase 1. Canadian Journal of Physiology and Pharmacology 99:10, pages 1069-1078.
Crossref
Eun Hye Park, Anna Shin, You-Jung Ha, Yun Jong Lee, Eun Bong Lee, Yeong Wook Song & Eun Ha Kang. (2021) Risk factors associated with initiation of a biologic disease modifying anti-rheumatic drug in patients with rheumatoid arthritis: A nested case-control study on 34,925 patients. Joint Bone Spine 88:1, pages 105057.
Crossref
Kichul Shin, Han Joo Baek, Young Mo Kang, Hoon-Suk Cha, Seong Wook Kang, Sung-Hwan Park, Jae-Bum Jun, Yun Jong Lee, In Ah Choi & Yeong Wook Song. (2019) Efficacy and safety of add-on tacrolimus versus leflunomide in rheumatoid arthritis patients with inadequate response to methotrexate. International Journal of Rheumatic Diseases 22:6, pages 1115-1122.
Crossref
Taio Naniwa, Shiho Iwagaitsu & Mikiko Kajiura. (2018) Long-term efficacy and safety of add-on tacrolimus for persistent, active rheumatoid arthritis despite treatment with methotrexate and tumor necrosis factor inhibitors. International Journal of Rheumatic Diseases 21:3, pages 673-687.
Crossref
Naoki Sugimoto, Ayako Nakajima, Eisuke Inoue, Kumi Shidara, Hiroyuki Yamashita, Akio Mimori, Hitoshi Tokuda, Yohei Seto, Eiichi Tanaka, Shigeki Momohara, Atsuo Taniguchi & Hisashi Yamanaka. (2017) Incidence of comprehensive hospitalization due to infection, cardiovascular disease, fractures, and malignancies in patients with rheumatoid arthritis. Rheumatology International 37:11, pages 1871-1878.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.